中心手术量对集中化ERCP成本效果的影响评估
本研究为成本效果分析,比较当前ERCP在高手术量(HV)与低手术量(LV)中心分布与假设全部集中于HV中心的场景。基线场景增量成本效果比为每年-$151,270,因假设场景成本更低且质量调整生命年略高。仅当交通成本超过$3655时研究结果改变。作者认为HV中心以更低成本实现高性能率,需考虑将ERCP集中化至HV中心以提高医疗质量。
要点
- 假设全部ERCP集中于高手术量中心,增量成本效果比为每年-$151,270。
- 仅交通成本超过$3655时,研究结果才会改变。
- 当前分布仅当LV中心成功率≥92.4%(vs 89.3%)且严重不良事件≤0.5%(vs 6.7%)时才具成本效果。
核心结论
- 高手术量中心以更低成本实现高性能率,作者提出需考虑将ERCP集中化至高手术量中心以提高医疗质量。
研究设计与样本
- 成本效果分析,比较当前ERCP在高手术量与低手术量中心分布与假设全部集中于高手术量中心的场景,并进行1项和2项敏感性分析及蒙特卡洛模拟的概率敏感性分析。
主要发现
- 基线场景增量成本效果比为每年-$151,270,因假设场景成本更低且质量调整生命年略高。
- 模型对交通成本变化最敏感(109.34%),其次为低手术量中心成功ERCP后严重不良事件概率(42.12%)、ERCP后伴严重不良事件效用值(30.10%)和高手术量中心成功ERCP后严重不良事件概率(23.53%)。
- 仅交通成本超过$3655时研究结果改变。
- 当前ERCP分布仅当低手术量中心达到更高成功率(≥92.4% vs 89.3%)且严重不良事件更低(≤0.5% vs 6.7%)时才具成本效果。
- 概率敏感性分析中合并所有模型参数后主要发现不变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: ERCP is a complex endoscopic procedure in which the center's procedure volume influences outcomes. With the increasing healthcare expenses and limited resources, promoting cost-effective care becomes essential for healthcare provision. This study was a cost-effectiveness analysis to evaluate the hypothesis that high-volume (HV) centers perform ERCP with higher quality at lower costs than low-volume (LV) centers. METHODS: A baseline case compared the current distribution of ERCPs among HV and LV centers with a hypothetical scenario in which all ERCPs are performed at HV centers. A cost-effectiveness analysis was constructed, followed by 1- and 2-way sensitivity analyses, and probabilistic sensitivity analysis using Monte Carlo simulations. RESULTS: In the baseline case, the incremental cost-effectiveness ratio was -$151,270 per year, due to the hypothetical scenario's lower costs and slightly higher quality-adjusted life years. The model was most sensitive to changes in transportation costs (109.34%), probability of significant adverse events (AEs) after successful ERCP at LV centers (42.12%), utility after ERCP with significant AEs (30.10%), and probability of significant AEs after successful ERCP at HV centers (23.53%); only transportation costs above $3655 changed the study outcome, however. The current ERCP distribution would only be cost-effective if LV centers achieved higher success (≥92.4% vs 89.3%), with much lower significant AEs (≤.5% vs 6.7%). The study's main findings remained unchanged while combining all model parameters in the probabilistic sensitivity analysis. CONCLUSIONS: Our findings show that HV centers have high-performance rates at lower costs, raising the need to consider the principle of centralization of ERCPs into HV centers to improve the quality of care.
引用
- Teles de Campos S, Diniz P, Castelo Ferreira F, et al. Assessing the impact of center volume on the cost-effectiveness of centralizing ERCP. Gastrointest Endosc. 2023. PMID: 38061478. doi:10.1016/j.gie.2023.11.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。